Semaglutide units to mg chart
Units on a syringe depend on your vial's strength. At 2.5 mg/mL, 0.25 mg is 10 units and 40 units is 1 mg. Find your strength on the label, then read your dose off the chart.
First, find your strength
Every chart below starts from one number: the strength of your vial in mg per mL. On a pharmacy vial it’s printed on the label, often as “2.5 mg/mL” or “5 mg/2 mL”. If it’s written as a total over a volume, divide: 5 mg in 2 mL is 2.5 mg/mL.
If you mixed the vial yourself, the strength is the mg in the vial divided by the mL of water you added. A 5 mg vial with 2 mL of water is 2.5 mg/mL.
Then the rule is: units = dose in mg ÷ strength × 100. The charts below apply it.
The label doses, in units
These are the weekly steps on the FDA labels, converted to units on a U-100 syringe. Wegovy steps up every 4 weeks through 0.25, 0.5, 1 and 1.7 mg to a usual maintenance dose of 2.4 mg (source 1). Ozempic starts at 0.25 mg, then 0.5 mg, and can go to 1 mg and then 2 mg (source 2). The doses come from the labels; this page only converts them.
| Weekly dose | At 1 mg/mL | At 2.5 mg/mL | At 5 mg/mL |
|---|---|---|---|
| 0.25 mg | 25 units | 10 units | 5 units |
| 0.5 mg | 50 units | 20 units | 10 units |
| 1 mg | 100 units | 40 units | 20 units |
| 1.7 mg | 170 units (over 1 mL) | 68 units | 34 units |
| 2 mg | 200 units (over 1 mL) | 80 units | 40 units |
| 2.4 mg | 240 units (over 1 mL) | 96 units | 48 units |
The same dose lands on very different lines depending on strength: 0.5 mg is 50 units at one strength and 10 at another. And a weak vial can make a dose too big for one syringe, which is a sign to check the strength again, not to draw twice without thinking it through.
The Wegovy label now also allows a 7.2 mg weekly dose for some adults after at least 4 weeks on 2.4 mg (source 1). At 5 mg/mL that would be 144 units, more than a 1 mL syringe holds.
Going the other way: units to mg
“How many mg is 40 units of semaglutide?” depends on the strength, the same way:
| Units drawn | At 1 mg/mL | At 2.5 mg/mL | At 5 mg/mL |
|---|---|---|---|
| 10 units | 0.1 mg | 0.25 mg | 0.5 mg |
| 20 units | 0.2 mg | 0.5 mg | 1 mg |
| 40 units | 0.4 mg | 1 mg | 2 mg |
| 50 units | 0.5 mg | 1.25 mg | 2.5 mg |
So 40 units is 1 mg at 2.5 mg/mL, but 2 mg at 5 mg/mL. If someone online says “I’m on 40 units,” that’s not a dose you can copy until you know their strength.
When a new vial changes the numbers
This is the moment most mistakes happen. A pharmacy or supplier changes the strength between refills, the label looks almost the same, and the old number of units carries on. Going from a 2.5 mg/mL vial to a 5 mg/mL vial at the same 20 units doubles the dose, from 0.5 mg to 1 mg.
The FDA has collected reports of people taking 5 to 20 times their intended dose of compounded semaglutide, with confusion between mg, mL and units behind many of them (source 3). Some needed hospital care. Every new vial is worth thirty seconds with the label and the calculator.
Pens are different
Branded pens (Ozempic, Wegovy) are set by clicks or give a fixed dose per pen. The charts on this page are for semaglutide drawn from a vial with an insulin syringe. If you have a pen, follow the dose steps on its own label.
FAQ
How many units is 0.25 mg of semaglutide? 10 units at 2.5 mg/mL, 5 units at 5 mg/mL and 25 units at 1 mg/mL.
How many mg is 40 units? 1 mg at 2.5 mg/mL, 2 mg at 5 mg/mL and 0.4 mg at 1 mg/mL.
My new vial is a different strength. What changes? The units. The same 20 units is 0.5 mg at 2.5 mg/mL and 1 mg at 5 mg/mL. Work it out again with every new vial.
Can I use these charts for a pen? No. Pens are set by clicks or give a fixed dose. Follow the dose steps on the pen’s own label.
Sources
- Wegovy (semaglutide) injection prescribing information, section 2: dosage and administration, Novo Nordisk, FDA label, June 2026.
- Ozempic (semaglutide) injection prescribing information, section 2: dosage and administration, Novo Nordisk, FDA label, June 2026.
- FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products, US Food and Drug Administration, July 2024.